UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 29, 2004
-------------
DOBI MEDICAL INTERNATIONAL, INC.
-------------------------------------------------------
(Exact name of registrant as specified in charter)
Delaware 0-32523 98-0222710
---------------- --------------- --------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
1200 MacArthur Blvd.
Mahwah, New Jersey 07430
-------------------------- ---------
(Address of principal (Zip Code)
executive offices)
Registrant's telephone number, including area code: (201) 760-6464
--------------
CURRENT REPORT ON FORM 8-K
DOBI MEDICAL INTERNATIONAL, INC.
July 29, 2004
Item 5. Other Events and Required FD Disclosure.
(a) As previously reported, DOBI Medical International, Inc. had agreed
with investors in its December 9, 2003 private placement to file on or around
April 1, 2004 a registration statement with the Securities and Exchange
Commission permitting the resale of their shares. In accordance with amended
waivers received from holders of 96% of the securities sold in that private
placement, DOBI Medical has further extended the date by which it will file its
"resale" registration statement to on or around September 30, 2004. Other than
with respect to 229,400 shares of common stock (approximately 4% of the total
securities sold), no penalties will accrue as a result of the waivers and
extensions from the private placement investors.
(b) On July 29, 2004, DOBI Medical International, Inc. issued a press
release announcing guidance for fiscal years 2004 and 2005. A copy of the press
release is furnished as Exhibit 99.1 to this report and is incorporated herein
by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
99.1 Press release of DOBI Medical International, Inc. issued July 29,
2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DOBI MEDICAL INTERNATIONAL, INC.
Dated: July 29, 2004 By:/s/ Phillip C. Thomas
-----------------------------------
Phillip C. Thomas
Chief Executive Officer